« Return to News | CROs/Service Providers

Prestwick, Pharma Plexus form strategic alliance

Tuesday, December 13, 2011 11:44 AM

Prestwick Chemical, a chemical services company for the life sciences industry, has formed a strategic alliance with Pharma Plexus Holland, a provider of pharmaceutical optimization and development services. The two companies will work together on a significant lead optimization project recently won from a major pharmaceutical company.

With this new partnership, the two companies can offer enhanced multidisciplinary research services to life science companies worldwide. The two companies will be working together to provide lead optimization and library services, large-scale synthesis and expect to offer further drug discovery services in the future.
 
“Prestwick Chemical was looking at solutions to expand its capacity and ability to handle larger projects in the face of growing demand,” said Professor Thierry Langer, CEO of Prestwick Chemical. “The collaboration with Pharma Plexus Holland in Weesp near Amsterdam is a great opportunity to do just this. It also allows us to address the additional needs of our clients and prospects. In Weesp, we have found scientists and entrepreneurs whose culture for excellence is perfectly aligned with that of our own scientists and we are looking forward to a long and successful collaboration.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.